IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling
IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Diabetic retinopathy (DR), one of the most serious complications of diabetes, has been associated with inflammatory processes. We have recently reported that interleukin (IL)-17A, a proinflammatory cytokine, is increased in the plasma of diabetic patients. Further investigation is required to clarify the role of IL-17A in DR.
Ins2
Akita
(A...
Alternative Titles
Full title
IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5192073
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5192073
Other Identifiers
ISSN
1226-3613
E-ISSN
2092-6413
DOI
10.1038/emm.2016.117
